PATRICE FOURON: Open Payments
NPI 1881942217 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 52 payments from 7 companies in 2025. Trend: 2023 $1,271 · 2024 $1,343 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $268 |
| Teva Pharmaceuticals USA, Inc. | 20 | $239 |
| Alkermes, Inc. | 10 | $239 |
| Neurocrine BioSciences, Inc. | 7 | $203 |
| Lundbeck LLC | 4 | $119 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Janssen Scientific Affairs, LLC | 1 | $28 |
Products named: INVEGA SUSTENNA, UZEDY, INGREZZA, VIVITROL, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
